nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—RNASE3—atopic dermatitis	0.37	0.493	CbGaD
Pranlukast—IL5—atopic dermatitis	0.329	0.439	CbGaD
Pranlukast—TNF—atopic dermatitis	0.0511	0.0681	CbGaD
Pranlukast—CYP3A4—Pimecrolimus—atopic dermatitis	0.0219	0.156	CbGbCtD
Pranlukast—ABCC2—Dexamethasone—atopic dermatitis	0.0169	0.12	CbGbCtD
Pranlukast—CYP2C9—Loratadine—atopic dermatitis	0.0164	0.117	CbGbCtD
Pranlukast—CYP2C9—Diphenhydramine—atopic dermatitis	0.0164	0.117	CbGbCtD
Pranlukast—CYP3A4—Tacrolimus—atopic dermatitis	0.013	0.0929	CbGbCtD
Pranlukast—CYP3A4—Loratadine—atopic dermatitis	0.00952	0.068	CbGbCtD
Pranlukast—CYP3A4—Methylprednisolone—atopic dermatitis	0.00871	0.0622	CbGbCtD
Pranlukast—CYP3A4—Triamcinolone—atopic dermatitis	0.0066	0.0471	CbGbCtD
Pranlukast—CYP2C9—Dexamethasone—atopic dermatitis	0.00566	0.0404	CbGbCtD
Pranlukast—CYP3A4—Betamethasone—atopic dermatitis	0.00566	0.0404	CbGbCtD
Pranlukast—CYP3A4—Prednisolone—atopic dermatitis	0.00559	0.0399	CbGbCtD
Pranlukast—CYP3A4—Hydrocortisone—atopic dermatitis	0.0053	0.0378	CbGbCtD
Pranlukast—CYP3A4—Prednisone—atopic dermatitis	0.00528	0.0377	CbGbCtD
Pranlukast—CYP3A4—Dexamethasone—atopic dermatitis	0.00329	0.0235	CbGbCtD
Pranlukast—IL5—Immune System—TLR2—atopic dermatitis	4.87e-05	0.000444	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL27—atopic dermatitis	4.85e-05	0.000442	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCR3—atopic dermatitis	4.84e-05	0.000441	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	4.83e-05	0.000441	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—CASP8—atopic dermatitis	4.83e-05	0.00044	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CARD11—atopic dermatitis	4.82e-05	0.000439	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MS4A2—atopic dermatitis	4.76e-05	0.000434	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CXCL10—atopic dermatitis	4.76e-05	0.000434	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—NFKBIA—atopic dermatitis	4.75e-05	0.000433	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—MAPK8—atopic dermatitis	4.75e-05	0.000433	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—NFKBIA—atopic dermatitis	4.75e-05	0.000433	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—TAC1—atopic dermatitis	4.75e-05	0.000433	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—NPS—atopic dermatitis	4.75e-05	0.000433	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL1B—atopic dermatitis	4.68e-05	0.000427	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL18—atopic dermatitis	4.66e-05	0.000425	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CXCR3—atopic dermatitis	4.66e-05	0.000424	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CARD11—atopic dermatitis	4.63e-05	0.000422	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—TNF—atopic dermatitis	4.63e-05	0.000422	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TNF—atopic dermatitis	4.63e-05	0.000422	CbGpPWpGaD
Pranlukast—NFKB1—Activated TLR4 signalling—MAPK8—atopic dermatitis	4.61e-05	0.000421	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—STAT6—atopic dermatitis	4.59e-05	0.000419	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD79A—atopic dermatitis	4.58e-05	0.000417	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—IL6—atopic dermatitis	4.53e-05	0.000413	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CCL5—atopic dermatitis	4.51e-05	0.000412	CbGpPWpGaD
Pranlukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	4.47e-05	0.000408	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—TNF—atopic dermatitis	4.46e-05	0.000407	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—MAPK8—atopic dermatitis	4.46e-05	0.000406	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—CXCL8—atopic dermatitis	4.44e-05	0.000405	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—IL5—atopic dermatitis	4.41e-05	0.000402	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	4.36e-05	0.000397	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL17—atopic dermatitis	4.35e-05	0.000396	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—MAPK8—atopic dermatitis	4.34e-05	0.000396	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—CXCL8—atopic dermatitis	4.34e-05	0.000395	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TAC1—atopic dermatitis	4.31e-05	0.000393	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—NPS—atopic dermatitis	4.31e-05	0.000393	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—TNF—atopic dermatitis	4.3e-05	0.000392	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—CASP8—atopic dermatitis	4.28e-05	0.00039	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	4.26e-05	0.000389	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—DEFB1—atopic dermatitis	4.25e-05	0.000387	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—NGF—atopic dermatitis	4.24e-05	0.000387	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—IL6—atopic dermatitis	4.24e-05	0.000387	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CXCR3—atopic dermatitis	4.23e-05	0.000385	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL1B—atopic dermatitis	4.16e-05	0.000379	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IFNG—atopic dermatitis	4.15e-05	0.000378	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—MAPK8—atopic dermatitis	4.14e-05	0.000378	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.1e-05	0.000374	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CCL5—atopic dermatitis	4.1e-05	0.000374	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—atopic dermatitis	4.09e-05	0.000373	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CCR5—atopic dermatitis	4.07e-05	0.000371	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	4.05e-05	0.000369	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL5—atopic dermatitis	4.01e-05	0.000365	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCR3—atopic dermatitis	3.98e-05	0.000363	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—TNF—atopic dermatitis	3.96e-05	0.000361	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—CASP8—atopic dermatitis	3.92e-05	0.000358	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	3.91e-05	0.000356	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL1B—atopic dermatitis	3.91e-05	0.000356	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	3.89e-05	0.000354	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KIF3A—atopic dermatitis	3.88e-05	0.000353	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	3.86e-05	0.000352	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CXCL8—atopic dermatitis	3.86e-05	0.000352	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—MAPK8—atopic dermatitis	3.81e-05	0.000348	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—IL6—atopic dermatitis	3.81e-05	0.000347	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—MAPK8—atopic dermatitis	3.8e-05	0.000346	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CXCL10—atopic dermatitis	3.76e-05	0.000343	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CASP1—atopic dermatitis	3.75e-05	0.000342	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL18—atopic dermatitis	3.74e-05	0.000341	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—IL2—atopic dermatitis	3.72e-05	0.000339	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL1B—atopic dermatitis	3.7e-05	0.000338	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 cascade initiated on plasma membrane—IL6—atopic dermatitis	3.7e-05	0.000337	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CCR5—atopic dermatitis	3.69e-05	0.000337	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD8A—atopic dermatitis	3.69e-05	0.000336	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL2—atopic dermatitis	3.69e-05	0.000336	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.68e-05	0.000336	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—CASP8—atopic dermatitis	3.68e-05	0.000336	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	3.67e-05	0.000334	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—IL1B—atopic dermatitis	3.66e-05	0.000334	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	3.6e-05	0.000328	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—IL6—atopic dermatitis	3.6e-05	0.000328	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TAC1—atopic dermatitis	3.55e-05	0.000324	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NPS—atopic dermatitis	3.55e-05	0.000324	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—IL6—atopic dermatitis	3.53e-05	0.000322	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CXCL8—atopic dermatitis	3.52e-05	0.000321	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IL6—atopic dermatitis	3.51e-05	0.00032	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL11—atopic dermatitis	3.5e-05	0.00032	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CMA1—atopic dermatitis	3.5e-05	0.00032	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—NFKBIA—atopic dermatitis	3.5e-05	0.000319	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCR3—atopic dermatitis	3.48e-05	0.000317	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	3.47e-05	0.000317	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—IL6—atopic dermatitis	3.47e-05	0.000317	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—IL6—atopic dermatitis	3.45e-05	0.000315	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CXCL10—atopic dermatitis	3.42e-05	0.000312	CbGpPWpGaD
Pranlukast—NFKB1—MyD88:Mal cascade initiated on plasma membrane—IL6—atopic dermatitis	3.41e-05	0.000311	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—TLR2—atopic dermatitis	3.4e-05	0.00031	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KIF3A—atopic dermatitis	3.39e-05	0.000309	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—atopic dermatitis	3.39e-05	0.000309	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—MAPK8—atopic dermatitis	3.36e-05	0.000306	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.32e-05	0.000303	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FCER2—atopic dermatitis	3.31e-05	0.000302	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—STAT6—atopic dermatitis	3.3e-05	0.0003	CbGpPWpGaD
Pranlukast—NFKB1—MyD88-independent cascade—IL6—atopic dermatitis	3.27e-05	0.000299	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	3.25e-05	0.000296	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CCL5—atopic dermatitis	3.24e-05	0.000295	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	3.22e-05	0.000294	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	3.2e-05	0.000292	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.18e-05	0.00029	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—IL6—atopic dermatitis	3.12e-05	0.000285	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CXCL8—atopic dermatitis	3.12e-05	0.000285	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.11e-05	0.000284	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—MAPK8—atopic dermatitis	3.1e-05	0.000282	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—atopic dermatitis	3.09e-05	0.000282	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	3.09e-05	0.000281	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL22—atopic dermatitis	3.08e-05	0.000281	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD79A—atopic dermatitis	3.07e-05	0.00028	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL6—atopic dermatitis	3.05e-05	0.000279	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	3.03e-05	0.000276	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	2.98e-05	0.000272	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	2.96e-05	0.00027	CbGpPWpGaD
Pranlukast—NFKB1—Activated TLR4 signalling—IL6—atopic dermatitis	2.95e-05	0.000269	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCL5—atopic dermatitis	2.94e-05	0.000268	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CCR5—atopic dermatitis	2.92e-05	0.000266	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—STAT6—atopic dermatitis	2.89e-05	0.000263	CbGpPWpGaD
Pranlukast—IL5—Immune System—NFKBIA—atopic dermatitis	2.86e-05	0.000261	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCR3—atopic dermatitis	2.86e-05	0.000261	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TNF—atopic dermatitis	2.82e-05	0.000257	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCL10—atopic dermatitis	2.81e-05	0.000256	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CARD11—atopic dermatitis	2.81e-05	0.000256	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—IL1B—atopic dermatitis	2.79e-05	0.000254	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—IL6—atopic dermatitis	2.77e-05	0.000253	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL27—atopic dermatitis	2.74e-05	0.00025	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL6—atopic dermatitis	2.74e-05	0.00025	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—MAPK8—atopic dermatitis	2.73e-05	0.000249	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IFNG—atopic dermatitis	2.73e-05	0.000249	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CXCL8—atopic dermatitis	2.66e-05	0.000243	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TNF—atopic dermatitis	2.66e-05	0.000242	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCR5—atopic dermatitis	2.65e-05	0.000242	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—IL6—atopic dermatitis	2.65e-05	0.000241	CbGpPWpGaD
Pranlukast—IL5—Immune System—CASP8—atopic dermatitis	2.58e-05	0.000235	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—MAPK8—atopic dermatitis	2.56e-05	0.000233	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—PPARA—atopic dermatitis	2.56e-05	0.000233	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TAC1—atopic dermatitis	2.55e-05	0.000232	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NPS—atopic dermatitis	2.55e-05	0.000232	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCR3—atopic dermatitis	2.5e-05	0.000228	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	2.5e-05	0.000228	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD8A—atopic dermatitis	2.47e-05	0.000225	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—IL6—atopic dermatitis	2.47e-05	0.000225	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL17—atopic dermatitis	2.46e-05	0.000224	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CXCL8—atopic dermatitis	2.46e-05	0.000224	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	2.44e-05	0.000222	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	2.43e-05	0.000222	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL2—atopic dermatitis	2.43e-05	0.000221	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCL5—atopic dermatitis	2.42e-05	0.000221	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	2.4e-05	0.000219	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL5—atopic dermatitis	2.37e-05	0.000216	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—IL2—atopic dermatitis	2.35e-05	0.000214	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—MAPK8—atopic dermatitis	2.34e-05	0.000213	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.31e-05	0.000211	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—atopic dermatitis	2.29e-05	0.000209	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.28e-05	0.000208	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NGF—atopic dermatitis	2.24e-05	0.000204	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CXCL8—atopic dermatitis	2.23e-05	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—MAPK8—atopic dermatitis	2.19e-05	0.0002	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KIF3A—atopic dermatitis	2.19e-05	0.0002	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.19e-05	0.0002	CbGpPWpGaD
Pranlukast—IL5—Immune System—IFNG—atopic dermatitis	2.19e-05	0.0002	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CASP1—atopic dermatitis	2.19e-05	0.000199	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCR5—atopic dermatitis	2.18e-05	0.000199	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL6—atopic dermatitis	2.17e-05	0.000198	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL2—atopic dermatitis	2.13e-05	0.000195	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD4—atopic dermatitis	2.12e-05	0.000193	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL5—atopic dermatitis	2.07e-05	0.000189	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	2.06e-05	0.000188	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCL10—atopic dermatitis	2.02e-05	0.000184	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IL6—atopic dermatitis	2.01e-05	0.000183	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—NFKBIA—atopic dermatitis	2e-05	0.000182	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CMA1—atopic dermatitis	1.98e-05	0.000181	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL11—atopic dermatitis	1.98e-05	0.000181	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TLR2—atopic dermatitis	1.98e-05	0.00018	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL6—atopic dermatitis	1.98e-05	0.00018	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1B—atopic dermatitis	1.96e-05	0.000178	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL2—atopic dermatitis	1.95e-05	0.000178	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—PPARA—atopic dermatitis	1.95e-05	0.000178	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—NFKBIA—atopic dermatitis	1.92e-05	0.000175	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	1.9e-05	0.000173	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—STAT6—atopic dermatitis	1.87e-05	0.00017	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD79A—atopic dermatitis	1.86e-05	0.00017	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NFKBIA—atopic dermatitis	1.85e-05	0.000169	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CASP8—atopic dermatitis	1.8e-05	0.000164	CbGpPWpGaD
Pranlukast—IL5—Immune System—MAPK8—atopic dermatitis	1.79e-05	0.000164	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.76e-05	0.000161	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL5—atopic dermatitis	1.74e-05	0.000158	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.73e-05	0.000158	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—IL2—atopic dermatitis	1.69e-05	0.000154	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCR3—atopic dermatitis	1.62e-05	0.000147	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NGF—atopic dermatitis	1.61e-05	0.000147	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CXCL8—atopic dermatitis	1.6e-05	0.000146	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCR5—atopic dermatitis	1.57e-05	0.000143	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.54e-05	0.000141	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL2—atopic dermatitis	1.53e-05	0.00014	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL18—atopic dermatitis	1.52e-05	0.000139	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD8A—atopic dermatitis	1.5e-05	0.000137	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL6—atopic dermatitis	1.49e-05	0.000136	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD4—atopic dermatitis	1.48e-05	0.000135	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TAC1—atopic dermatitis	1.44e-05	0.000131	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NPS—atopic dermatitis	1.44e-05	0.000131	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL6—atopic dermatitis	1.43e-05	0.00013	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD4—atopic dermatitis	1.42e-05	0.000129	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCR3—atopic dermatitis	1.41e-05	0.000129	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IL6—atopic dermatitis	1.4e-05	0.000128	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL5—atopic dermatitis	1.34e-05	0.000122	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NFKBIA—atopic dermatitis	1.33e-05	0.000121	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCL8—atopic dermatitis	1.32e-05	0.00012	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL2—atopic dermatitis	1.26e-05	0.000115	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL6—atopic dermatitis	1.25e-05	0.000114	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MAPK8—atopic dermatitis	1.25e-05	0.000114	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NFKBIA—atopic dermatitis	1.16e-05	0.000106	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MAPK8—atopic dermatitis	1.16e-05	0.000106	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL6—atopic dermatitis	1.15e-05	0.000104	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL10—atopic dermatitis	1.14e-05	0.000104	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—atopic dermatitis	1.12e-05	0.000102	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CASP8—atopic dermatitis	1.05e-05	9.56e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL5—atopic dermatitis	9.84e-06	8.97e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GLB1—atopic dermatitis	9.77e-06	8.91e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCL8—atopic dermatitis	9.46e-06	8.63e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ADSL—atopic dermatitis	9.37e-06	8.54e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NGF—atopic dermatitis	9.11e-06	8.31e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—atopic dermatitis	9.05e-06	8.25e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL2—atopic dermatitis	9.04e-06	8.25e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—atopic dermatitis	9e-06	8.21e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IFNG—atopic dermatitis	8.91e-06	8.13e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCR5—atopic dermatitis	8.86e-06	8.08e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD4—atopic dermatitis	8.61e-06	7.85e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MAPK8—atopic dermatitis	8.33e-06	7.59e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—atopic dermatitis	7.99e-06	7.29e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1B—atopic dermatitis	7.95e-06	7.25e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL2—atopic dermatitis	7.92e-06	7.22e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NFKBIA—atopic dermatitis	7.51e-06	6.85e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—atopic dermatitis	7.41e-06	6.75e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MAPK8—atopic dermatitis	7.29e-06	6.65e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	7.12e-06	6.49e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—atopic dermatitis	6.9e-06	6.29e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GLB1—atopic dermatitis	6.44e-06	5.88e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ADSL—atopic dermatitis	6.18e-06	5.63e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL8—atopic dermatitis	5.36e-06	4.89e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—atopic dermatitis	5.32e-06	4.85e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL2—atopic dermatitis	5.12e-06	4.67e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAPK8—atopic dermatitis	4.71e-06	4.3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—atopic dermatitis	4.66e-06	4.25e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPARA—atopic dermatitis	3.17e-06	2.89e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—atopic dermatitis	3.01e-06	2.74e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.09e-06	1.91e-05	CbGpPWpGaD
